New diagnostic kits aim to revolutionize early screening of the disease, potentially allowing patients to receive ...
Labcorp plans to offer Roche’s recently FDA-cleared blood test to assess early signs of Alzheimer’s disease and other causes of cognitive decline for patients 55 years and older. The blood test, which ...
Coeliac disease is an immune-based condition in which the body’s immune system reacts to gluten by attacking itself, resulting in inflammation that can lead to many different symptoms. Currently ...
The test can also pinpoint which organ or tissue in the body has cancer - helping give patients the right scans A “HOLY grail” blood test can pick up cancer cases with 84 per cent accuracy – even ...
A second blood test has been been approved by the US Food and Drug Administration to assist in diagnosing Alzheimer’s disease. Will these tests change how cognitive decline is measured? A new blood ...
Around four years ago, now 77-year-old John Gormly went for what was supposed to be a routine blood test. But the results were life-changing. The test suggested Gormly had colon cancer, which a ...
The U.S. Food and Drug Administration has cleared another blood test that could help doctors identify whether a patient's memory problems are likely caused by Alzheimer's disease. The new test, called ...
The Food and Drug Administration has given approval for a blood test that will rule out if someone has Alzheimer’s disease and other cognitive issues when they have the symptoms of the conditions. It ...
The U.S. Food and Drug Administration has given clearance to another blood test to help assess Alzheimer’s disease and other causes of cognitive decline, providing a broader understanding of when the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results